# Flo Health Inc. account plan

> Flo Health makes the Flo women's health app: $208,759,632 FY2025 revenue from premium subscriptions, 79.3 million monthly active users.

## At a glance

Flo Health develops and markets the Flo app, a women's health app for cycle, fertility, pregnancy and perimenopause tracking and insights; it was the company's sole product as of 31 December 2025. The operating company, Flo Health UK Limited, is headquartered in London with subsidiaries in Cyprus, Lithuania and the Netherlands, and is wholly owned by Flo Health Inc. (USA), which raised a round led by General Atlantic in August 2024. FY2025 group revenue was $208,759,632, up 24%, with a loss before tax of $22,440,423 and Monthly Active Users of 79.3 million. The average headcount in 2025 was 459, of which 348 in software development.

## Business units

- **App Store subscriptions** (about 76% of FY2025 revenue ($158,322,431)): Flo Premium subscriptions sold through Apple's App Store, the dominant channel; revenue rose from $130,725,025 in 2024.
- **Google Play subscriptions** (about 13% of FY2025 revenue ($27,772,862)): Flo Premium subscriptions sold through Google Play, up from $22,515,120 in 2024.
- **Web (direct-to-consumer) subscriptions** (about 11% of FY2025 revenue ($22,556,670)): Subscriptions sold on Flo's own website, paid through PayPal and Stripe. Website channel revenue rose 52% in 2025 after investment in the site and marketing.

## Strategic priorities

- **Perimenopause and new life stages**: 2025 launches included Perimenopause Mode and Peri Score; the company plans to support additional life stages such as perimenopause, and its new CMO is tasked with reaching the 40+ demographic.
- **Clinical-grade, regulated features**: Flo is moving from a wellness app to features such as symptom evaluations and risk assessments that need FDA compliance, and stood up a quality management system with Ketryx in about twelve weeks.
- **AI in the product**: Ask Flo and pre-generated chatbot journeys were expanded in 2025; machine learning underpins cycle predictions.
- **Wearables and the Google Health partnership**: A Sleep Experience with wearable integration launched in 2025, and a multi-year partnership with Google Health announced on 12 October 2026 will sync Flo with Google Health from early next year, with joint research and new products.
- **Direct-to-consumer web channel**: Flo keeps investing in its website as a direct-to-consumer channel; web subscription revenue reached $22,556,670 in 2025, up 52%.
- **Privacy, security and compliance**: The directors expect a strong focus on privacy, security and regulatory compliance; the company is ISO 27001 certified.

## Latest results

In FY2025 (year to 31 December 2025) revenue grew 24% to $208,759,632 and Monthly Active Users rose 9% to 79.3 million. The loss before tax widened to $22,440,423 (2024: $18,862,641) on higher advertising and employee-related costs, and EBITDA was $(16,029,082). The United States contributed $102,032,489 of revenue and the United Kingdom $22,872,795. No guidance is given; Flo Health Inc. has confirmed financial support until 31 December 2027.

## Investments and deals

- **Research and development**: R&D expense was $59,465,759 in 2025 (2024: $44,845,222), and $5.1 million of development costs were capitalised.
- **Debt refinancing**: On 29 April 2025 a new $30.0 million facility ($10.0 million term loan, $20.0 million revolver, with an accordion of up to $15.0 million) refinanced the previous growth capital loan.
- **London and Vilnius offices**: A new 10-year London lease signed in January 2026 (right-of-use asset of approximately $9.7 million) and a Vilnius office lease signed in December 2025 (approximately $4.3 million).
- **Google Health partnership**: Multi-year strategic partnership announced on 12 October 2026 covering app syncing, Google Health Coach integration, research and new products for women.
- **Marketing leadership**: Rina Hahn, former CMO of Remitly, joined as Chief Marketing Officer on 26 August 2026, based in London.

## Challenges and risks

- **Losses**: Loss for the year was $21,288,255 in 2025 and total equity was negative, with going concern resting on parent support.
- **Sensitive health data**: The group processes sensitive personal and health-related data and is exposed to cyber-attack, data loss and regulatory action.
- **Consumer demand and marketing efficiency**: Premium subscription demand depends on consumer discretionary spending, competition, marketing efficiency and the mobile platform and digital advertising environments.
- **Competition from large platforms**: Flo's CTO names Apple's Health app as a competitor and calls Flo relatively small by comparison.
- **Regulatory compliance**: Digital health products face data protection, consumer protection and medical device requirements.

## What leadership says

> "Rina is precisely the person we need for this role and our next phase." — Dmitry Gurski, CEO, Flo Health press release appointing Rina Hahn as CMO, 26 August 2026

> "we are competing with Apple. Like, they have Apple Health app." — Roman Bugaev, Chief Technology Officer, Ketryx webinar How Flo Is Building Regulatory Readiness, Fast, 11 November 2025

> "greater clarity, confidence and hope to women everywhere" — Rina Hahn, Chief Marketing Officer, Flo Health press release on her appointment, 26 August 2026


## Where a supplier can help

- **Regulated software tooling**: Tied to the clinical-grade features priority: vendors of QMS, testing, CI/CD and compliance automation can help Flo keep release speed while building FDA-regulated features.
- **Security and privacy**: Tied to the sensitive health data challenge: security monitoring, privacy engineering and data governance suppliers fit a group that processes health data and keeps ISO 27001 certification.
- **Performance marketing and growth**: Tied to rising advertising costs and the new CMO's remit: measurement, creative, influencer and web conversion tools that improve marketing efficiency and the direct-to-consumer web channel.
- **Wearable and data integration**: Tied to the Google Health partnership and the Sleep Experience: health data integration, analytics and ML infrastructure for syncing biometric data with cycle predictions.
- **Workplace and engineering talent**: Tied to the London and Vilnius office investments and a headcount of 459: office services, hiring and developer productivity tools.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Flo Health UK Limited - Annual Report and Financial Statements, year ended 31 December 2025 (group accounts, Companies House)](https://find-and-update.company-information.service.gov.uk/company/12898410/filing-history/MzUyNjQ5NTg1M2FkaXF6a2N4/document?format=pdf&download=0)

Annual report · 2026-06-23

- Flo Health UK Limited, a wholly owned subsidiary of Flo Health Inc. (USA), develops and markets the Flo app, a women's health app for tracking and insights across the reproductive lifecycle; the Flo app was its sole product as of 31 December 2025. Headquarters in London; subsidiaries in Cyprus, Lithuania and the Netherlands.
- FY2025 group revenue was $208,759,632, up 24% from $168,213,691 in 2024; Monthly Active Users rose 9% to 79.3 million (72.8 million).
- Still loss-making: loss before tax $22,440,423 (2024: $18,862,641), EBITDA $(16,029,082), loss for the year $21,288,255, mainly from higher advertising and employee-related costs.
- Revenue is premium subscriptions: App Store $158,322,431, Google Play $27,772,862 and the Flo website $22,556,670, the web channel up 52% after investment in direct-to-consumer.
- The United States is the largest market at $102,032,489 of revenue, then the United Kingdom ($22,872,795), Australia, Germany and Canada.
- 2025 product launches: a perimenopause user journey (Perimenopause Mode, Peri Score), Community enhancements, Ask Flo chatbot, pre-generated chatbot journeys and a Sleep Experience with wearable integration.
- Research and development expense was $59,465,759 (2024: $44,845,222); the average headcount was 459, of which 348 in software development.
- Refinanced in April 2025 with a new $30.0 million term and revolving facility ($10.0 million term loan, $20.0 million revolver); Flo Health Inc. confirmed financial support until 31 December 2027.
- Since the August 2024 fundraising led by General Atlantic, Palta Group no longer controls the group; the ultimate parent is Flo Health Inc.
- Key risks named: data protection and cybersecurity, market and demand, product development, regulatory and product compliance.

### [We're partnering with Flo Health to elevate women's health (Google Health announcement)](https://blog.google/products-and-platforms/products/google-health/commitment-womens-health-flo-health-partnership/)

Report · 2026-10-12

- On 12 October 2026 Google Health announced a "landmark, multi-year strategic partnership" with Flo Health, which it describes as used by more than 80 million women every month.
- Beginning early next year, users will be able to sync the Flo Health app with the Google Health app, linking cycle data with metrics such as resting heart rate, heart rate variability, skin temperature and sleep stages; Google Health data will also be available to Flo.
- Flo data will feed Google Health Coach (with Google Health Premium) for cycle-aware guidance, including for perimenopause.
- The two will partner on research into underserved topics, which may include perimenopause, polyendocrine metabolic ovarian syndrome (PMOS), pregnancy and postpartum recovery.
- They will build new products for women combining Flo's insights and algorithms with Google's wearable hardware and sensors (Fitbit Air, Pixel Watch 5, Fitbit Edge are named).
- Strict opt-in: Flo data shared with Google Health "will never be used for advertising, never be sold".
- Google calls it "just the beginning of a long-term partnership".

### [Flo Health appoints Rina Hahn as Chief Marketing Officer (press release)](https://flo.health/newsroom/flo-rina-hahn-chief-marketing-officer)

Report · 2026-08-26

- On 26 August 2026 Flo Health appointed Rina Hahn, former CMO of Remitly (NASDAQ: RELY), as Chief Marketing Officer.
- At Remitly she built and led a 150 person global marketing organization through an IPO, covering acquisition, brand and lifecycle across 170+ countries.
- She is based in Flo's London office and leads brand, social, influencer, paid media, user acquisition and communications.
- Her brief: reach the 40+ demographic, leaning into the recent perimenopause offerings, and guide expansion initiatives planned for H2 of 2026 and beyond.
- CEO Dmitry Gurski: "Rina is precisely the person we need for this role and our next phase."
- Flo describes itself as supporting 80 million monthly active users, with 100+ medical experts and 28M Flo Premium subscriptions donated through its Pass it on Project.

### [How Flo Is Building Regulatory Readiness, Fast (Ketryx webinar with Flo's CTO, Chief Legal and Compliance Officer and Director of Engineering)](https://llm.ketryx.com/transcripts/webinars/How%20Flo%20Is%20Building%20Regulatory%20Readiness%2C%20Fast.md)

Executive talk · Roman Bugaev, Chief Technology Officer · 2025-11-11

- Flo is moving from a wellness app ("a digital version of the book") to clinical-grade features (symptom evaluations, risk assessments) that need FDA compliance; CTO Roman Bugaev says the goal is to be the "essential health partner for all women around the world".
- With compliance vendor Ketryx, Flo stood up a quality management system (QMS) in about twelve weeks; Ketryx's CEO says 87 days.
- Flo runs about 400 concurrent A/B tests and more than a thousand a year, and releases multiple times a day across the app.
- The app is treated as a multifunction device: medical features sit under the QMS, while social features such as the community stay outside.
- About twenty percent of women aged 18-35 in the UK use Flo, by Bugaev's estimate, with a similar figure in the US; the app is free in many countries in Africa, in India and in Ukraine.
- Bugaev names Apple's Health app as a competitor and calls Flo "relatively small" by comparison, so it must move fast.
- Machine learning underpins cycle predictions; engineers also use AI to write code and documentation.
- Advice from the three: treat regulation as a "growth enabler", use "compliance by design", automate as much as possible.

### [Subversive podcast: How Best-In-Class Retention Propelled Flo to a $1B Valuation (Dmitry Gurski)](https://www.buzzsprout.com/2432582/episodes/18019336-how-best-in-class-retention-propelled-flo-to-a-1b-valuation)

Podcast · Dmitry Gurski, Co-founder and CEO · 2025-10-16

- Subversive (host Phil Carter) interviews Dmitry Gurski, cofounder and CEO of Flo, on growth and retention; this summary is built from the episode's detailed published show notes and chapter list, not a full transcript.
- The show notes state Flo has 450 million installs, 80 million MAUs and $300M in ARR, and is the #1 health app in the world.
- Two early contrarian bets: free period tracking as an organic acquisition engine, and one "super app" covering conception, pregnancy and perimenopause, giving category-leading long-term retention.
- Retention compounds active users and word of mouth, creating "an efficient growth engine".
- Flo runs thousands of experiments per year with 200 to 300 active at any time, moving trial start and conversion rates.
- Flo focuses on Relative Net Revenue Retention (RNRR) and balances free-user retention with monetization.
- Flo for Partners, launched in 2023, has >2M male users in Partner Mode; Flo believes it can grow to >10M partners over the next few years.

## Questions about Flo Health Inc.

### What does Flo Health do?

Flo Health develops the Flo app, a women's health app for cycle, fertility, pregnancy and perimenopause tracking and insights. It earns revenue from Flo Premium subscriptions sold through the App Store, Google Play and its website.

### What is Flo Health's revenue?

Group revenue of Flo Health UK Limited was $208,759,632 in FY2025, up 24% from $168,213,691 in 2024, with a loss before tax of $22,440,423.

### How many employees does Flo Health have?

The average monthly headcount was 459 in 2025, of which 348 in software development services, 66 in corporate services and 45 in software promotion.

### Who owns Flo Health?

Flo Health UK Limited is wholly owned by Flo Health Inc., incorporated in the USA. Since a fundraising led by General Atlantic in August 2024, Palta Group no longer controls the group.

### Who leads Flo Health?

Dmitry Gurski is co-founder and CEO. Roman Bugaev is CTO and Rina Hahn became Chief Marketing Officer in August 2026.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)_
